Stocks
Lantheus Holdings, Inc.LNTH
NASDAQHealthcareBiotechnology$79.49-1.16%
Develops and commercializes diagnostic radiopharmaceuticals and contrast agents used in medical imaging, particularly for oncology and cardiology. Its flagship product, Pylarify, is a PSMA-targeted PET imaging agent widely used in detecting and staging prostate cancer, driving a significant share of...
Market Cap: $5.3B52W Range: $47.25 – $108.91
Congressional Interest in Lantheus Holdings, Inc. (LNTH)
1 member of Congress has disclosed 4 trades in Lantheus Holdings, Inc. (LNTH), a Healthcare company. The buy/sell breakdown shows 4 purchases versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
4
Unique Politicians
1
Buys
4
Sells
0
Who in Congress Is Trading LNTH?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2025-01-28 | Gilbert Cisneros | buy | $1K – $15K |
| 2025-01-13 | Gilbert Cisneros | buy | $1K – $15K |